Description
Indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2,3-dioxygenase (IDO), a promising target for anti-cancer immunotherapy.| Period | 6 Jul 2011 → 8 Jul 2011 |
|---|---|
| Event type | Conference |
| Location | Lyon, FranceShow on map |
Documents & Links
Related content
-
Projects
-
Research output
-
Discovery and optimization of indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2-3 dioxygenase (IDO), a promising target for anti-cancer immunotherapy.
Research output: Contribution to journal › Literature review › peer-review
-
Indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2,3 dioxygenase (IDO), a promising target for anti-cancer immunotherapy
Research output: Contribution to conference › Poster
-
Indole-pyridinyl-ethanones as novel inhibitors of indoleamine-2,3-dioxygenase (IDO), a promising target for anti-cancer immunotherapy
Research output: Contribution to conference › Poster
-
Indoleamine 2,3-Dioxygenase Inhibitory Activity of Derivatives of Marine Alkaloid Tsitsikammamine A
Research output: Contribution to journal › Article › peer-review
-
Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Research output: Contribution to journal › Article › peer-review
-
Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Research output: Contribution to journal › Article › peer-review
-
Discovery and Optimization Of Indole-pyridinyl-ethanones as Novel Inhibitors of Indoleamine-2,3-Dioxygenase (IDO), a Promising Target for Anti-Cancer Immunotherapy
Research output: Contribution to conference › Poster
-
Novel Inhibitors of Indoleamine 2,3-Dioxygenase (IDO), a Target for Anti-Cancer Immunotherapy
Research output: Contribution to conference › Poster
-
Indole-pyridinyl-ethanones as Novel Inhibitors of Indoleamine 2,3-Dioxygenase (IDO), a Promising Target forAnti-Cancer Immunotherapy
Research output: Contribution to conference › Poster
-
Indoleamine 2,3-Dioxygenase Inhibitory Activity of Derivatives of Marine Alkaloid Tsitsikammamine A
Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution
-
Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008-2012)
Research output: Contribution to journal › Literature review › peer-review